For numerous decades, generic drugs have been offering relief from
the ever-increasing costs of branded prescription drugs. In many
developing countries, generic drugs still remain a key element for
governments to offer cost-effective medications to the people. The
launch of new generic drugs by startups and key companies has
benefited the global market. The availability of generic drugs at
affordable prices is the key factor expected to propel the global
market through the forecast period.
A new report in the market intelligence repository of
QYResearchReports.com, titled ‘Global Generic Drugs Market
Professional Survey Report 2016,’ highlights the types,
applications, and classifications of generic drugs. The analysts also
focus on various regions where key companies operate and offer their
services. Based on region, the global market for generic drugs is
divided into North America, Europe, Asia Pacific, and Rest of the
World. After focusing on the dominance of key companies in various
regions, the analysts have briefed readers about technical
advancements, capacity production, commercial production,
manufacturing plants, the status of research and development
activities, and sources of raw materials of generic drugs.
To Get Sample Copy of Report visit @
http://www.qyresearchreports.com/sample/sample.php?rep_id=760522&type=E
Prominent players in the global generic drugs market are profiled
with information such as product pictures, specifications, product
type, sales of generic drugs, ex-factory price, gross margin, and
revenue. The study also focuses on key companies willing to acquire
the new entrants in the market. Some of the prominent players listed
in the report are Teva Pharma., Novartis Company, Mylan, Allergan,
Hospira, Dr. Reddy’s Lab., Stada, Greenstone, Par Pharma, Sun
Pharmaceutical, Aspen Pharmacare, Fresenius, Lupin. Currently,
prominent players are concentrating on improving their research and
development activities to discover new generic drugs. With this, they
are expected to maintain their dominance in the global market.
The availability of advanced medical devices and the implementation
of new technologies in manufacturing procedures have helped
manufacturers in introducing new generic drugs. Over the past decade,
sales of generic copies of branded medicines have been increasing.
Browse Complete Report with TOC @
http://www.qyresearchreports.com/report/global-generic-drugs-market-professional-survey-report-2016.htm
The report highlights the key factors expected to drive the global
generic drugs market in the coming years. Rising patent expiry has
prevented manufacturers of branded drugs from expanding the lifecycle
of their products. Thus, the global market for generic drugs has
expanded and is further predicted to flourish at a rapid pace.
However, the changing regulations in many nations are predicted to
hamper the growth of the global generic drugs market. In many
nations, governments have made it mandatory for healthcare centers,
hospitals, and medical centers to supply prescription drugs, which
might affect the sales of generic drugs.
To conclude, the report measures the feasibility of new projects that
are planned by key companies. SWOT analysis and other such
industry-standard tools are used by manufacturers of generic drugs to
measure the feasibility of the new projects. Factors such as
international trade figures, import, export, commercial production,
and capacity production of generic drugs are highlighted in the
report by the analysts.
About Us
QYReseachReports.com
delivers the latest strategic market intelligence to build a
successful business footprint in China. Our syndicated and customized
research reports provide companies with vital background information
of the market and in-depth analysis on the Chinese trade and
investment framework, which directly affects their business
operations. Reports from QYReseachReports.com feature valuable
recommendations on how to navigate in the extremely unpredictable yet
highly attractive Chinese market.
Our sector-specific
research reports include, but are not limited to: Chemicals,
Materials, Energy, Glass, Alternative Energy, Automotives, and
Pharmaceuticals. We cater to MNCs, SMEs, private equity firms, and
prestigious Chinese enterprises. Our experienced and
commitment-driven research team works in close collaboration with
clients to help them find the most suitable market research reports
or to transform complex data into objective market intelligence.
Contact Us
1820 Avenue
M Suite #1047
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Email: sales@qyresearchreports.com
Comments
Post a Comment